miR-92a-1-5p delivered by PCa EVs could downregulate type I collagen expression by directly targeting COL1A1 and thus promoting osteoclast differentiation and inhibiting osteoblastogenesis. The gene discussed is COL1A1; the disease is posterior cortical atrophy.